Oxford Conversis Limited
Registered name: OXFORD CONVERSIS LIMITED
Part of Iqvia Holdings Inc. groupOxford Conversis Limited made £7.7m revenue and a £90.5k loss in the year to 31 Dec 2025.
Oxford Conversis Limited’s revenue grew 20% to £7.7m in the year to 31 Dec 2025, with a loss of £90.5k and 67 employees. The company is classified under “translation and interpretation activities” and is based in Reading; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Reading, South East
- Age
- 23 yrs · since 2002
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | No P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | — | — | £6.4m | £7.7m |
| Cost of sales | — | — | £3.9m | £4.4m |
| Gross profit | — | — | £2.5m | £3.3m |
| Operating profit | — | — | £721k | £153k |
| Profit before tax | — | — | £724k | £153k |
| Profit after tax | — | — | £536k | −£90.5k |
| Profit (best available) | — | — | £536k | −£90.5k |
| Employees (average) | 41 | 48 | 56 | 67 |
| Ratios | ||||
| Profit margin | — | — | 8.3% | −1.2% |
| Gross margin | — | — | 38.9% | 42.7% |
| Revenue per employee | — | — | £115k | £115k |
| Profit per employee | — | — | £9.6k | −£1.4k |
| Growth (year on year) | ||||
| Revenue growth | — | — | — | ▲19.9% |
| Profit growth | — | — | — | ▼116.9% |
| Headcount growth | — | ▲17.1% | ▲16.7% | ▲19.6% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £408k | £868k | £1.4m | £1.9m |
| Net assets | £2m | £2.4m | £2.8m | £2.5m |
| Fixed assets | £634k | £567k | £503k | £462k |
| Current assets | £2.4m | £3.4m | £3.6m | £4.3m |
| Debtors | £1.4m | £1.9m | £1.4m | £1.4m |
| Deferred income | £287k | £682k | £800k | £1.6m |
| Source | FullAccounts · bulk data May 2024 | FullAccounts · bulk data May 2024 | FullAccounts · bulk data Jul 2025 | FullAccounts · bulk data Aug 2026 |
How the business works
- Profit margin
- −1.2%
- Profit ÷ revenue.
- Gross margin
- 42.7%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £115k
- Revenue ÷ average employees.
- Profit per employee
- −£1.4k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 6%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 21.1%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 18.4%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼11%
- Now £2.5m
- Cash at bank
- ▲37%
- Now £1.9m
- Headcount
- ▲20%
- Now 67
- Deferred income
- ▲103%
- Now £1.6m
- Fixed assets
- ▼8%
- Now £462k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Iqvia Holdings Inc. (registered outside the UK register)ultimate parent75–100%
- Iqvia RDS UK Holdings Ltd.75–100%
- Iqvia RDS Holdings75–100%
- Iqvia Ltd.75–100%
- Oxford Conversis Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (28)
- Interface Clinical Services LtdRev. £26.3m · Profit £5.9m
- Pharmareview LimitedRev. £6m · Profit £47.8m
- Epg Communication Holdings LimitedRev. £2.5m · Profit −£4.3m
- Apira LimitedFigures not disclosed
- Arc Bio Communications LimitedRev. — · Profit £1.8m
- Clintec International Ltd.Figures not disclosed
- Cro Solutions LimitedRev. — · Profit £1.1m
- Drugdev LimitedFigures not disclosed
- Gce Clin Solutions LimitedFigures not disclosed
- Healthcare Business Information LimitedFigures not disclosed
- Ims (UK) Pension Plan Trustee Company LimitedFigures not disclosed
- Iqvia Biotech Ltd.Figures not disclosed
- Iqvia Investment Holdings LimitedFigures not disclosed
- Iqvia Solutions Finance UK V Ltd.Figures not disclosed
- Iqvia Solutions UK LimitedFigures not disclosed
- Iqvia Technology Services Ltd.Figures not disclosed
- LH Perspectives LimitedFigures not disclosed
- Linguamatics LimitedFigures not disclosed
- Linguamatics Solutions LimitedFigures not disclosed
- Medicines Evaluation Unit LimitedRev. — · Profit £2.4m
- Optimum Contact LimitedFigures not disclosed
- Pharmadeals LimitedFigures not disclosed
- Pharmaspectra Group LtdRev. — · Profit £1.6m
- Pharmaspectra Topco LtdLiquidationFigures not disclosed
- PHR Topco LimitedLiquidationRev. — · Profit −£1.8m
- Prioritis LimitedFigures not disclosed
- Q Squared Solutions Holdings LimitedFigures not disclosed
- QH Research LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Link Up Mitaka LimitedLeeds · Translation and interpretation activities
- Revenue
- £8.5m
- Profit
- £659k
- Staff
- 77
- Significan't (UK) LimitedSheffield · Translation and interpretation activities
- Revenue
- £13.7m
- Profit
- £1.2m
- Staff
- 74
- Word360 LtdEdgbaston · Translation and interpretation activities
- Revenue
- £16.9m
- Profit
- £3.8m
- Staff
- 52
- Sign Language Interactions LimitedGlasgow · Translation and interpretation activities
- Revenue
- £19m
- Profit
- £1.9m
- Staff
- 121
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£90.5k), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.